Key Moments
Genetic Screening of Embryos: Risks and Benefits
Key Moments
Genetic screening of embryos offers trait selection but raises ethical concerns and lacks conclusive evidence for benefits beyond specific cases.
Key Insights
Preimplantation Genetic Testing (PGT) allows selection of embryos based on genetic makeup, moving beyond chance in inheritance.
PGT encompasses various tests: PGT-A (aneuploidy), PGT-M (monogenic diseases), PGT-SR (structural rearrangements), and PGT-P (polygenic traits).
PGT-A's benefit is most evident for women nearing the end of their fertile years, but outcomes are highly dependent on lab quality.
PGT-M is effective for single-gene disorders but relies on understanding gene-disease correlation, which isn't always deterministic.
PGT-P, for polygenic traits like height or intelligence, is the most controversial due to unreliability in current data and ethical implications.
Legal regulations for embryo genetic screening vary significantly worldwide, with some countries prohibiting sex selection and others having no specific laws.
INTRODUCTION TO PREIMPLANTATION GENETIC TESTING (PGT)
The advent of Preimplantation Genetic Testing (PGT) marks a significant shift, allowing prospective parents to influence their child's genetic inheritance beyond chance. Typically performed on three-to-five-day-old embryos, PGT involves analyzing cells for genetic makeup to decide which embryos to implant or discard. This technology, often integrated with In-Vitro Fertilization (IVF), is becoming increasingly common globally, with a notable percentage of IVF procedures incorporating these screenings.
TYPES OF GENETIC SCREENING TESTS AVAILABLE
PGT encompasses several distinct types of tests. PGT-A screens for aneuploidy, or abnormal chromosome numbers, identifying conditions such as Down syndrome. PGT-M targets single-gene disorders like cystic fibrosis or Huntington's disease. PGT-SR investigates structural chromosomal rearrangements that can lead to developmental issues. Finally, PGT-P, the most debated, assesses polygenic traits influenced by multiple genes, including predispositions to common diseases or complex traits like intelligence and height.
EFFICACY AND BENEFITS OF PGT-A AND PGT-M
PGT-A, the most common type, shows a potential benefit for women nearing the end of their reproductive years by increasing the chances of a successful pregnancy and reducing miscarriage rates. However, the effectiveness is highly dependent on the laboratory's proficiency. PGT-M is valuable for families with known hereditary genetic diseases, offering a way to avoid passing these conditions to offspring, though the interpretation of risk and genetic predisposition remains complex.
THE CONTROVERSIAL REALM OF PGT-P AND POLYGENIC TRAITS
PGT-P is highly controversial because it examines traits influenced by numerous genes, where genetic factors often indicate only an increased likelihood rather than a certainty of developing a condition. The technology uses sophisticated AI to analyze correlations between specific DNA markers (SNPs) and health outcomes. While simulations suggest potential risk reduction for diseases and even enhancements in traits like height or IQ, the reliability of these predictions is hampered by data biases and a lack of clinical validation in embryos.
ETHICAL DILEMMAS SURROUNDING TRAIT SELECTION
The ability to select genetic traits for offspring raises profound ethical questions. Concerns include potential parental bias in selecting for traits like intelligence or height over health, the possibility of creating 'savior siblings' for medical donation, and the long-term societal impact of altering human genetic diversity. The definition of what constitutes a 'disease' versus a 'trait' is subjective, leading to complex moral considerations about parental autonomy and the child's future well-being.
REGULATORY LANDSCAPE AND FUTURE IMPLICATIONS
Legal frameworks for PGT vary significantly across the globe. Some nations, like EU member states, restrict PGT to preventing severe hereditary diseases and often prohibit sex selection. Others, such as China and the US, have fewer legal restrictions, leading to a 'wild west' scenario in some instances, particularly regarding non-medical trait selection. The lack of robust, long-term clinical trials for all PGT types means definitive conclusions about their overall benefit and risk are still evolving.
Mentioned in This Episode
●Software & Apps
●Tools
●Companies
●Organizations
●Books
●Studies Cited
●Concepts
●People Referenced
Genetic Screening of Embryos: A Quick Guide
Practical takeaways from this episode
Do This
Avoid This
Common Questions
PGT is a genetic screening process performed on embryos, typically three to five days old, by analyzing several cells to determine their genetic makeup. Based on the results, parents and doctors decide whether to implant the embryo or discard it.
Topics
Mentioned in this video
A company that offers polygenic tests.
A company that offers polygenic tests, similar to Genomic Predictions.
An American company founded in 2017 that offers polygenic testing for various diseases and traits. They were behind the world's first PGT-P baby, Aurea.
A platform offering online courses in science and mathematics, including computational biology, neural networks, and quantum computing. A promotional link is provided.
A fertility treatment that involves fertilizing an egg outside the body. PGT is often applied to embryos created through IVF.
A genetic disorder caused by a third copy of chromosome 18, detectable through PGT-A tests.
A monogenic disease tested for using PGT-M, caused by a single gene defect.
A type of genetic screening test used for conditions caused by a single gene defect, capable of avoiding over six hundred known monogenic diseases.
A genetic screening test that looks for uncommon chromosome rearrangements, which can be associated with intellectual disability, speech delay, or birth defects.
A genetic disorder caused by a third copy of chromosome 21, detectable through PGT-A tests. Individuals with Down syndrome often have distinctive physical features, lower IQ, and potential heart conditions, but can live into their 60s with good medical support.
The most controversial type of genetic screening test, which screens for traits influenced by multiple genes, including diseases like diabetes and heart conditions, as well as traits like height and intelligence.
A method performed on embryos (typically 3-5 days old) to analyze their genetic makeup, determining whether to discard or implant them.
A genetic condition caused by a missing or damaged second X chromosome, detectable through PGT-A tests.
Used by companies like Genomic Predictions to analyze large DNA databases and identify correlations between gene expressions and health problems for risk prediction.
A genetic disorder caused by a third copy of chromosome 13, detectable through PGT-A tests.
A monogenic disease commonly tested for using PGT-M.
A study examining IVF candidates in Europe and Israel that found PGT-A screening did not increase successful pregnancy outcomes but slightly decreased miscarriage risk.
A study using a California clinic's data that found PGT-A patients had a higher chance of having a child across all age groups, but the difference was smaller than in previous studies.
A monogenic disease tested for using PGT-M, caused by a single gene defect.
An American study suggesting PGT-A benefits increased pregnancy chances by over threefold for women older than 37, though the sample size was small (60 women).
A paper indicating PGT-A doubled pregnancy chances for women over 38 but decreased them in younger age groups, highlighting confusing results.
Has varying regulations on genetic screening, generally forbidding sex-selection and permitting polygenic screening only for incurable hereditary diseases.
An authority that has rated PGT-A as 'red' due to insufficient evidence of benefit, indicating caution.
A journal where a 2019 paper was published simulating the effects of polygenetic screening for height and IQ over generations.
More from Sabine Hossenfelder
View all 55 summaries
7 minBreakthrough In Data Storage Could Store Your Photos for 10000 Years
7 minThe Simulation Hypothesis Gets Scientific Backing
7 minSurprise! Milky Way Might Not Have a Black Hole After All
7 minThe First Moon Landing Wasn’t Apollo — And We Just Found It
Found this useful? Build your knowledge library
Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.
Try Summify free